Your browser doesn't support javascript.
loading
Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes.
Zeidan, Amer M; Bewersdorf, Jan Philipp; Buckstein, Rena; Sekeres, Mikkael A; Steensma, David P; Platzbecker, Uwe; Loghavi, Sanam; Boultwood, Jacqueline; Bejar, Rafael; Bennett, John M; Borate, Uma; Brunner, Andrew M; Carraway, Hetty; Churpek, Jane E; Daver, Naval G; Della Porta, Matteo; DeZern, Amy E; Efficace, Fabio; Fenaux, Pierre; Figueroa, Maria E; Greenberg, Peter; Griffiths, Elizabeth A; Halene, Stephanie; Hasserjian, Robert P; Hourigan, Christopher S; Kim, Nina; Kim, Tae Kon; Komrokji, Rami S; Kutchroo, Vijay; List, Alan F; Little, Richard F; Majeti, Ravi; Nazha, Aziz; Nimer, Stephen D; Odenike, Olatoyosi; Padron, Eric; Patnaik, Mrinal M; Roboz, Gail J; Sallman, David A; Sanz, Guillermo; Stahl, Maximilian; Starczynowski, Daniel T; Taylor, Justin; Xie, Zhuoer; Xu, Mina; Savona, Michael R; Wei, Andrew H; Abdel-Wahab, Omar; Santini, Valeria.
Afiliação
  • Zeidan AM; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA. amer.zeidan@yale.edu.
  • Bewersdorf JP; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Buckstein R; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada.
  • Sekeres MA; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Steensma DP; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Platzbecker U; Leipzig University Hospital, Leipzig, Germany.
  • Loghavi S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Boultwood J; Blood Cancer UK Molecular Haematology Unit, Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
  • Bejar R; Division of Hematology and Oncology, Moores Cancer Center, UC San Diego, La Jolla, CA, USA.
  • Bennett JM; Hematopathology Division, Departments of Pathology and Medicine, University of Rochester Medical Center, Rochester, NY, USA.
  • Borate U; Division of Hematology, Department of Internal Medicine, James Cancer Center, Ohio State University, Columbus, OH, USA.
  • Brunner AM; Leukemia Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
  • Carraway H; Leukemia Program, Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Churpek JE; Department of Hematology, Oncology, and Palliative Care, Carbone Cancer Center, The University of Wisconsin-Madison, Madison, WI, USA.
  • Daver NG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Della Porta M; Department of Biomedical Sciences, Humanitas Clinical and Research Center & Humanitas University, Milan, Italy.
  • DeZern AE; Johns Hopkins Sidney Kimmel Comprehensive Cancer Centre, Baltimore, MD, USA.
  • Efficace F; Italian Group for Adult Hematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Rome, Italy.
  • Fenaux P; Hôpital Saint Louis, Paris, France.
  • Figueroa ME; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Greenberg P; Division of Hematology, Department of Medicine, Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
  • Griffiths EA; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Halene S; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA.
  • Hasserjian RP; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
  • Hourigan CS; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
  • Kim N; National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Kim TK; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Komrokji RS; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
  • Kutchroo V; Evergrande Center for Immunologic Diseases, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.
  • List AF; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
  • Little RF; Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Majeti R; Division of Hematology, Department of Medicine, Cancer Institute, and Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA.
  • Nazha A; Department of Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.
  • Nimer SD; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Odenike O; The University of Chicago Medicine and University of Chicago Comprehensive Cancer Center, Chicago, IL, USA.
  • Padron E; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
  • Patnaik MM; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
  • Roboz GJ; Weill Cornell Medical College, New York, NY, USA.
  • Sallman DA; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
  • Sanz G; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain; Health Research Institute La Fe, Valencia, Spain; and CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.
  • Stahl M; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Starczynowski DT; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
  • Taylor J; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Xie Z; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
  • Xu M; Departments of Pathology & Laboratory Medicine, Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA.
  • Savona MR; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Wei AH; Peter MacCallum Cancer Centre, Royal Melbourne Hospital, University of Melbourne and Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.
  • Abdel-Wahab O; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Santini V; University of Florence Medical School, Florence, Italy.
Leukemia ; 36(12): 2939-2946, 2022 12.
Article em En | MEDLINE | ID: mdl-36266326
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mieloide Aguda / Transtornos Mieloproliferativos / Neoplasias Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mieloide Aguda / Transtornos Mieloproliferativos / Neoplasias Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos